LXRP News and Press, Lexaria Bioscience Corp. From 06/04/20

(via TheNewswire) KELOWNA, BC - TheNewswire - June 4, 2020 - Christopher Bunka, Chief Executive Officer and director of Lexaria Bioscience Corp. (the " Company "), (CNSX:LXX.CN) of 100 - 740 McCurdy Road, Kelowna, BC V1X 2P7, announces his intention to file an ear...

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) , a global innovator in drug delivery platforms, on Monday announced that it has retained PCG Advisory, Inc. ("PCG") of New York, to provide investor relations and digital marketing services to the Company in compliance with regulatory guideli...

(via TheNewswire) KELOWNA, BC - TheNewswire - June 1, 2020 - Lexaria Bioscience Corp. (OTC: LXRP ) (CSE: LXX ) (CNSX:LXX.CN) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms, announces it has retained PCG Advisory, Inc. ("PCG") of ...

Lexaria Bioscience (CSE: LXX) (OTCQX: LXRP) , a global innovator in drug delivery platforms, on Monday announced the close of its private placement financing. The company issued a total amount of 8,028,254 shares of its common stock along with common stock purchase warrants to purchase up to ...

(via TheNewswire) KELOWNA, BC - TheNewswire - May 11, 2020 - Lexaria Bioscience Corp. (OTC: LXRP ) (CSE: LXX ) (CNSX:LXX.CN) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms, today confirms that its private placement financing as...

Lexaria Bioscience ( OTCQX:LXRP -5.3% ) has entered into definitive agreements with certain qualified investors for the sale of 8,978,260 shares of common stock along with common stock purchase warrants to purchase up to same number of common shares in a private placement for gross proce...

(via TheNewswire) K elowna , BC - TheNewswire - May 4, 2020 - Lexaria Bioscience Corp. (OTC: LXRP ) (CSE: LXX ) (CNSX:LXX.CN) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms, today announced that it has entered into definitiv...

KELOWNA, BC / ACCESSWIRE / April 23, 2020 / Lexaria Bioscience Corp. (OTCQX:LXRP)(CSE:LXX) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms, has received a Notice of Allowance from the United States Patent and Trademark Office ("USPTO") for a new patent which provi...

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) , a global innovator in drug delivery platforms, today announced that it has filed an important new patent application in the United States describing the use of its DehydraTECH(TM) technology for the delivery of antiviral drugs. According to ...

(via TheNewswire) Kelowna, British Columbia - TheNewswire - April 21, 2020 - Lexaria Bioscience Corp. (OTC:LXRP) (CSE:LXX) (CNSX:LXX.CN) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms, has filed an important new patent application in...